Market Place
Sourcing Support
Solid Biosciences at 29th ASGCT Annual Meeting
30 Apr 2026 //
GLOBENEWSWIRE
Solid Biosciences To Participate At Upcoming Investor Conferences
07 Apr 2026 //
GLOBENEWSWIRE
Solid Bio Announces $240M Oversubscribed Private Placement
06 Mar 2026 //
GLOBENEWSWIRE
Solid Biosciences to Present at 2026 MDA Scientific Conference
06 Mar 2026 //
GLOBENEWSWIRE
Solid Biosciences To Present At Guggenheim Biotech Summit 2026
06 Feb 2026 //
GLOBENEWSWIRE
Solid Biosciences Initiates Phase 1B FALCON Trial For SGT-212
12 Jan 2026 //
GLOBENEWSWIRE
Solid Biosciences To Present At J.P. Morgan Healthcare Conference
06 Jan 2026 //
GLOBENEWSWIRE
Solid Biosciences Unveil AAV-SLB101 Cardiac Therapy at CVCT Forum
08 Dec 2025 //
GLOBENEWSWIRE
Solid Biosciences Grants Inducements Under Nasdaq Rule 5635(c)(4)
01 Dec 2025 //
GLOBENEWSWIRE
Solid Bio Announces Licensing Agreement with Andelyn Biosciences
17 Nov 2025 //
GLOBENEWSWIRE
Solid Biosciences To Participate At Upcoming Investor Conferences
11 Nov 2025 //
GLOBENEWSWIRE
Solid Bio Reports Q3, Updates INSPIRE Duchenne Trial Progress
03 Nov 2025 //
GLOBENEWSWIRE
Solid Biosciences To Participate At Upcoming Investor Conferences
30 Oct 2025 //
GLOBENEWSWIRE
Solid Biosciences To Present At Upcoming Scientific Meetings
01 Oct 2025 //
GLOBENEWSWIRE
Solid Biosciences Licenses Kinea Bio`s Proprietary AAV-SLB101
23 Sep 2025 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Solid Biosciences Reports Q1 2025 Results and Business Updates
15 May 2025 //
GLOBENEWSWIRE
Solid Biosciences to Present at ASGCT`s 28th Annual Meeting
29 Apr 2025 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
07 Apr 2025 //
GLOBENEWSWIRE
Solid Biosciences To Present At 2025 MDA Clinical Conference
12 Mar 2025 //
GLOBENEWSWIRE
Solid Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
04 Mar 2025 //
GLOBENEWSWIRE
Solid Bio Reports Positive Data For Duchenne Gene Therapy SGT-003
18 Feb 2025 //
GLOBENEWSWIRE
Solid Bio Gets FDA Fast Track For SGT-212 In Friedreich’s Ataxia
21 Jan 2025 //
GLOBENEWSWIRE
Jim Wilson Comments on FDA IND Clearance for Friedreich`s Ataxia
08 Jan 2025 //
PR NEWSWIRE
Solid Biosciences Gets FDA IND For Dual Route Therapy In Ataxia
07 Jan 2025 //
GLOBENEWSWIRE
Solid Biosciences Added to the Nasdaq Biotechnology Index
23 Dec 2024 //
GLOBENEWSWIRE
Solid Bio Collaborates with Mayo Clinic on Cardiac Gene Therapies
04 Dec 2024 //
GLOBENEWSWIRE
Solid Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Dec 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
26 Nov 2024 //
GLOBENEWSWIRE
Solid Bio to Present at Jefferies London Healthcare Conference
14 Nov 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Q3 2024 Financials & Updates
06 Nov 2024 //
GLOBENEWSWIRE
Solid Bio to Present at Truist Securities BioPharma Symposium
31 Oct 2024 //
GLOBENEWSWIRE
Solid Bio Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
03 Oct 2024 //
GLOBENEWSWIRE
Solid Bio To Attend Chardan Genetic Medicines Conference
23 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
12 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences to Participate at Upcoming Investor Conferences
04 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grants Under Nasdaq Rule
04 Sep 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Q2 2024 Results And Business Updates
13 Aug 2024 //
GLOBENEWSWIRE
Solid Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05 Aug 2024 //
GLOBENEWSWIRE
Solid Biosciences Provides Q1 2024 Business Update, Financials
15 May 2024 //
GLOBENEWSWIRE
AAV Manufacturing Takes Center Stage at ASGCT24
07 May 2024 //
BIOSPACE
Solid Biosciences Receives FDA Fast Track Designation for SGT-003
07 Dec 2023 //
GLOBENEWSWIRE
Solid Biosciences Announces IND Clearance by FDA for SGT-003
14 Nov 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides Second Quarter Business Update and Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Solid Biosciences to Participate at the Barclays Gene Editing & Therapy Summit
22 May 2023 //
GLOBENEWSWIRE
Solid Biosciences to Present at the American Society of Gene and Cell Therapy
16 May 2023 //
GLOBENEWSWIRE
Solid Biosciences Provides First Quarter Business Update and Financial Results
11 May 2023 //
GLOBENEWSWIRE
